BI 1595043

DRUG3 trials

Sponsors

Boehringer Ingelheim

Conditions

Healthy

Phase 1

A Study in Healthy Men to Test How Different Doses of BI 1595043 Are Tolerated

CompletedNCT04439838

Boehringer IngelheimHealthy

Start: 2020-08-13End: 2021-03-19Updated: 2024-02-21

A Study in Healthy Men to Test How BI 1595043 is Taken up in the Body When Given With or Without Food

CompletedNCT04789291

Boehringer IngelheimHealthy

Start: 2021-05-18End: 2021-08-07Updated: 2024-02-22

A Study to Test How Healthy Men Tolerate Different Doses of BI 1595043

CompletedNCT04789304

Boehringer IngelheimHealthy

Start: 2021-04-01End: 2022-01-14Updated: 2024-02-21